Search
for
Sort by
Research 331–360 of 1000+
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- Female Antiandrogens
- Effect of Carbamates on mRNA Encoding Lipid Enzymes in Hamster Flank Organs
- Androgen replacement therapy in women
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities
- Hormonal Therapy for Acne
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- Skin manifestations of hyperandrogenism: an update
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Suety and Spreading-Stromal Hyperplasia and Hyperthecosis Ovary
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Measurement of Steroid Hormones in Hair: an Analysis of Hormone Dynamics in Hair Follicles
- Iperandrogenismo della donna in menopausa
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Evaluación endocrinológica en el acné
- Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Managing hair loss in midlife women
- Virilization in a postmenopausal woman: Ovarian Leydig cell tumor
- Hormonal acne: leading to a paradigm shift in the management of acne
- Clinical Approaches to PCOS: A Survey of the NASPAG Membership
- Androgen Levels Do Not Predict PCOS Phenotypes in Adolescents and Young Adults
- Screening for Abnormal Glucose Metabolism in Adolescents with Polycystic Ovary Syndrome (PCOS)
- Modelling androgen synthesis and action during human sexual differentiation
- Androgen Treatment in Women
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia